Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs episode artwork

EPISODE · Dec 14, 2021 · 11 MIN

Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs

from The Journal of Clinical Psychopharmacology Podcast

A large observational study from researchers at Washington University in St. Louis found an elevated risk of breast cancer in women who take some types of antipsychotic drugs – specifically, drugs that raise levels of the hormone prolactin. In this podcast, Dr. Tahir Rahman, lead author of the study, discusses the findings and their implications for patient care.

Episode metadata supplied by the publisher feed · Published Dec 14, 2021

Embed this episode

NOW PLAYING

Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs

0:00 11:40

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Journal of Clinical Psychopharmacology Podcast?

This episode is 11 minutes long.

When was this The Journal of Clinical Psychopharmacology Podcast episode published?

This episode was published on December 14, 2021.

Can I download this The Journal of Clinical Psychopharmacology Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!